De Luca M, Aiuti A, Cossu G, Parmar M, Pellegrini G, Robey PG ABSTRACT Despite many reports of putative stem-cell-based treatments in genetic and degenerative disorders or severe injuries, the number of proven stem cell therapies has remained small. In…
De Rosa L, Secone Seconetti A, De Santis G, Pellacani G, Hirsch T, Rothoeft T, Teig N, Pellegrini G, Bauer JW, De Luca M ABSTRACT Laminin 332-deficient junctional epidermolysis bullosa (JEB) is a severe genetic skin disease. JEB is marked by epidermal stem cell depletion, the origin of which is…
Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, Pellegrini G, Shimmura S, Kruse FE; and The International Limbal Stem Cell Deficiency Working Group ABSTRACT Purpose: Despite extensive knowledge gained over the last 3 decades regarding limbal stem…
Lincoln V, Cogan J, Hou Y, Hirsch M, Hao M, Alexeev V, De Luca M, De Rosa L, Bauer JW, Woodley DT, Chen M.Lincoln V, Cogan J, Hou Y, Hirsch M, Hao M, Alexeev V, De Luca M, De Rosa L, Bauer JW, Woodley DT, Chen M. ABSTRACT…
Modena, 23 giugno 2010 - La comunità scientifica internazionale riconosce il successo di una terapia avanzata tutta italiana, basata sul trapianto autologo di epitelio corneale ricostruito in laboratorio grazie alle cellule staminali. Questa tecnica innovativa consente di restituire l’integrità della…
